Chlamydia Diagnostics Market is expected to grow at a CAGR of 11% to reach US$ 3.69 Billion during forecast period of 2023 to 2033 | Future Market Insights, Inc.

NAATs Expected to Hold 49% Of Market Share for Chlamydia diagnostics Market. The Chlamydia Diagnostics Market refers to the market for tests and assays that are used for the diagnosis of chlamydia infection. Chlamydia is a sexually transmitted infection caused by the bacteria Chlamydia trachomatis. It is one of the most common sexually transmitted infections worldwide, and is a leading cause of infertility in women

/EIN News/ -- DUBAI, United Arab Emirates, March 28, 2023 (GLOBE NEWSWIRE) -- By the year 2033, the global chlamydia diagnostics market is expected to rise up to a market valuation of US$ 3.69 Billion. Growth of the market can be attributed to Increasing awareness about the importance of STI testing.

The chlamydia diagnostics market in Europe is expected to witness substantial growth in the coming years, driven by several factors. The increasing prevalence of chlamydia in the region is one of the major drivers of the market. According to a report by the European Centre for Disease Prevention and Control, the number of reported chlamydia cases in Europe has been steadily increasing over the past decade, with over 410,000 cases reported in 2019. This rising incidence of chlamydia is expected to drive the demand for chlamydia diagnostics in the region.

The availability of advanced diagnostic tests is another significant factor contributing to the growth of the chlamydia diagnostics market. Nucleic acid amplification tests (NAATs) are the most commonly used diagnostic tests for chlamydia, as they offer high sensitivity and specificity.

Get a PDF Sample with Latest Market Insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16838

Moreover, these tests can detect the presence of the bacterial DNA in a patient's urine, swab, or blood sample, making them a convenient and non-invasive option for patients. Rapid diagnostic tests, such as the Alere i platform and the Roche Cobas Liat System, have also been introduced in recent years, allowing for quick and accurate diagnosis of chlamydia.

Key Takeaways from the Market Study

• By test type, NAATs are expected to hold 49% of the market share in 2023 for Chlamydia diagnostics market.
• The global Chlamydia diagnostics market is expected to grow with a 11% CAGR during 2023 to 2033.
• North America is expected to possess 48% market share for Chlamydia diagnostics market in 2023.
• Europe Chlamydia diagnostics market size is expected to possess 46% market share in 2023.

“Many organizations and governments are taking steps to raise awareness about the risks of STIs and the importance of early diagnosis and treatment. This, in turn, is expected to drive the growth of the market.” states an FMI analyst

Competitive Landscape

Key players in the chlamydia diagnostics market are Abbott Laboratories, F. Hoffmann-La Roche Ltd, Hologic, Inc., Quidel Corporation, DiaSorin SpA Becton, Dickinson and Company, Bio-Rad Laboratories, Pfizer, Inc., AstraZeneca and Teva Pharmaceuticals

• Abbott has Laboratories collaborated with BASHH to develop and distribute the BASHH Chlamydia Quality Assurance Scheme. This program aims to improve the quality of chlamydia testing in clinical laboratories by providing a framework for quality assurance and standardization.
• The Roche has developed Cobas 4800 CT/NG test is a nucleic acid amplification test (NAAT) that can detect the DNA of both Chlamydia trachomatis and Neisseria gonorrhoeae in various clinical samples, such as urine, swabs, and endocervical samples. The assay is highly sensitive and specific and has been widely adopted by clinical laboratories for chlamydia and gonorrhea testing.

Ask from Market Research Expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-16838

More Valuable Insights

Future Market Insights, in its new offering, presents an unbiased analysis of the global Edward’s syndrome treatment market, presenting historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.

The study reveals essential insights on the basis of Test Type (Culture Tests, Nucleic Acid Amplification Tests (NAAT), Direct Fluorescent Antibody Tests, Serology Tests) End User (Hospitals, Clinics, Diagnostic Centres) Region (North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East & Africa)

Key Segments Profiled in the Chlamydia Diagnostics Industry Survey

Test Type:

• Culture Tests
• Nucleic Acid Amplification Tests (NAAT)
• Direct Fluorescent Antibody Tests
• Serology Tests

End User:

• Hospitals
• Clinics
• Diagnostic Centres
  

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa
  

For more Report Customization, connect with us at@ https://www.futuremarketinsights.com/customization-available/rep-gb-16838

Table of Content

1. Executive Summary | Chlamydia Diagnostics Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

Read More TOC..

Get Full Access@ https://www.futuremarketinsights.com/reports/chlamydia-diagnostics-market

Explore FMI’s related ongoing Coverage on Healthcare Market Insights Domain

Lateral Flow Assays Market Share: The lateral flow assay market size is projected to be valued at US$ 4.3 billion in 2023 and is expected to rise to US$ 6.9 billion by 2033. The sales of lateral flow assay are expected to register a CAGR of 4.7% during the forecast period.

Surgical Instruments Tracking System Market Growth: The global surgical instrument tracking system market is estimated to reach a valuation of US$ 255 billion in 2023. As per Future Market Insights (FMI) analysis, the surgical instrument tracking system market size is expected to surpass S$ 940 billion in the next decade. Between 2023 and 2033, the market has been forecast to register a 13.9% CAGR.

Endometrial Ablation Market Demand: The Endometrial Ablation Market was valued at US$ 3.2 Billion in 2022 and is expected to grow with a CAGR of 7.3% from 2023 to 2033. 

Pleural Diseases Therapeutics Market Size: Expected to be valued at US$ 4.98 billion in 2023, the market for pleural diseases therapeutics is estimated to register a compounded annual growth rate (CAGR) of 6.5% from 2023 to 2033. According to Future Market Insights, the market is expected to reach US$ 9.4 billion by the end of the said forecast period.

Optic Atrophy Management Market Opportunity: The global optic atrophy management market is expected to reach a valuation of US$ 8 billion in 2023 and is projected to exhibit a CAGR of 4.9% from 2023 to 2033. By the end of the aforementioned forecast period, the market is likely to close at US$ 15.63 billion.

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Contact Us:

Future Market Insights, Inc.
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A, 
Jumeirah Lakes Towers, Dubai,
United Arab Emirates 
LinkedIn| Twitter| Blogs | YouTube
For Sales Enquiries: sales@futuremarketinsights.com